{"number":"US12702632B2","kindCode":"B2","documentType":"grant","title":{"original":"Protease formulation for treatment of microbial infections","english":"Protease formulation for treatment of microbial infections"},"abstract":{"original":"The present invention relates to a stable protease formulation. Furthermore, it relates to a stable protease formulation for use in medicine and cosmetics, as well as a method of preventing and reducing biofilm formulation.","english":"The present invention relates to a stable protease formulation. Furthermore, it relates to a stable protease formulation for use in medicine and cosmetics, as well as a method of preventing and reducing biofilm formulation."},"applicants":["ZYMIQ Technology AB"],"inventors":["Mats Clarsund"],"filingDate":"2022-11-07","publicationDate":"2026-08-11","grantDate":"2026-08-11","verifiedWithOffice":true,"pdfUrl":"https://downloadpatent.com/pdf/US12702632B2.pdf","pages":{"en":"https://downloadpatent.com/patent/US12702632B2","zh-Hant":"https://downloadpatent.com/zh-Hant/patent/US12702632B2","ja":"https://downloadpatent.com/ja/patent/US12702632B2"}}